ONCS OncoSec Medical Incorporated

CUSIP No. 68234L108

Page 2 of 5

CUSIP No. 68234L108

Page 3 of 5

This Amendment No. 2 is being filed jointly by the Reporting Persons and amends the Schedule 13G initially filed by the Reporting Persons with the Securities and Exchange Commission (the “ SEC ”) on April 2, 2012, as amended by Amendment No. 1 thereto filed with the SEC on February 12, 2013 (the “ Schedule 13G ”).

Except as set forth below, all Items of the Schedule 13G remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13G.

Item 4. Ownership.

(a) and (b):

As of the close of business on December 31, 2013, each of the Reporting Persons may be deemed to have beneficial ownership of 8,972,573 shares of Common Stock, which consists of (i) 1,300,000 shares of Common Stock in the aggregate issuable upon the exercise of warrants held by Managed Account 1 (the “ Managed Account 1 Warrants ”) and (ii) 7,672,573 shares of Common Stock in the aggregate issuable upon the exercise of warrants held by Cranshire Capital Master Fund (the “ Cranshire Warrants ”), and all such shares of Common Stock represent beneficial ownership of approximately 4.99% of the Common Stock, based on (1) 170,838,526 shares of Common Stock issued and outstanding on December 13, 2013, as reported in the Form 10-Q filed by the Issuer on December 16, 2013, plus (2) 1,300,000 shares of Common Stock in the aggregate issuable upon the exercise of the Managed Account 1 Warrants, and (3) 7,672,573 shares of Common Stock in the aggregate issuable upon the exercise of the Cranshire Warrants.

The foregoing excludes an aggregate of 11,525,552 shares of Common Stock issuable upon exercise of the Cranshire Warrants because each of the Cranshire Warrants contains a blocker provision under which the holder thereof does not have the right to exercise such Cranshire Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may be deemed to have beneficial ownership of 20,498,125 shares of Common Stock.

(c) Number of shares as to which each Reporting Person has:

(i) Sole power to vote or to direct the vote: 0 .

(ii) Shared power to vote or to direct the vote: 8,972,573 .

(iii) Sole power to dispose or to direct the disposition of 0 .

(iv) Shared power to dispose or to direct the disposition of 8,972,573 .

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following   x .

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Page 4 of 5

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 13, 2014

Page 5 of 5